Content about Nociception

May 3, 2013

Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

SAN DIEGO — Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

The study, scheduled for presentation to reporters at the American Urological Association's annual scientific meeting in San Diego on Tuesday, was conducted by researchers at New York University and the Waitemata District Health Board in Auckland, New Zealand, compared CPPS in young women who used oral contraceptives with the condition in those who didn't.

April 9, 2013

A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

ALEXANDRIA, Va. — A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

February 1, 2013

Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

OAKLAND, Calif. — Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

The study, which the healthcare system called the first to show a significant difference in risk between short-acting and long-acting opioids, appeared in The Clinical Journal of Pain.

October 9, 2012

There’s a new option for chronic pain sufferers that ought to spark some growth across external analgesics, including heat and ice packs: Omron’s recently approved ElectroTherapy Pain Relief unit.

LAKE FOREST, Ill. — There’s a new option for chronic pain sufferers that ought to spark some growth across external analgesics, including heat and ice packs: Omron’s recently approved ElectroTherapy Pain Relief unit. There are as many as 60 million chronic pain sufferers, according to the American Chronic Pain Association. And of those in search of pain relief solutions, 80% seek more than one type, according to research conducted on behalf of Thermionics. So Omron’s $69.99 transcutaneous electrical nerve stimulation unit should be an adjunctive sale.

March 9, 2012

A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

WASHINGTON — A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

October 31, 2011

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

TITUSVILLE, N.J. — A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

October 31, 2011

Performance Health this summer expanded its Perform product family with the introduction of Perform Pain Relieving Singles.

AKRON, Ohio — Performance Health this summer expanded its Perform product family with the introduction of Perform Pain Relieving Singles. The single-use format provides the benefits of cold therapy in an innovative, no-touch, no-mess package that’s small enough to fit in a pocket.

October 17, 2011

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

BEDMINSTER, N.J. — Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

Archimedes announced the launch of Lazanda (fentanyl) nasal spray for adult patients who have developed a tolerance to opioid therapy for persistent, underlying cancer pain. The drug uses Archimedes' patented PecSys delivery system, which allows the drug to be absorbed across the nasal membrane and directly into the bloodstream. The Food and Drug Administration approved the drug on June 30.

September 29, 2011

The American Pharmacists Association is marking Pain Awareness Month by encouraging patients to talk with their pharmacists about pain and pain medications they're taking.

WASHINGTON — The American Pharmacists Association is marking Pain Awareness Month by encouraging patients to talk with their pharmacists about pain and pain medications they're taking.

According to a recent report by the Institute of Medicine, more than 116 million Americans suffer from chronic pain, which costs the country up to $635 billion per year.

September 6, 2011

Overweight people with lower back pain is more intense than people of normal weight with back pain, according to a recent study published in the Sept. 15 issue of Spine.

PHILADELPHIA — Overweight people with lower back pain is more intense than people of normal weight with back pain, according to a recent study published in the Sept. 15 issue of Spine.

The study sets up another comorbidity associated with being overweight.

August 26, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating chronic pain, a J&J subsidiary said Friday.

RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating chronic pain, a J&J subsidiary said Friday.

The FDA approved Janssen Pharmaceuticals' Nucynta ER (tapentadol) tablets, an extended-release drug for moderate to severe chronic pain in adults for whom a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

August 18, 2011

Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

RARITAN, N.J. — Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

J&J subsidiary Janssen Pharmaceuticals added resources and tools to PrescribeResponsibly.com for physicians and pharmacists to support appropriate and responsible treatment of pain. The site was originally launched early last year.

July 25, 2011

Boiron is making headway introducing a whole new natural external pain reliever into the mass outlet, having earlier this year won distribution through Walgreens and Duane Reade of its arnica gel Arnicare.

NEWTON SQUARE, Pa. — Boiron is making headway introducing a whole new natural external pain reliever into the mass outlet, having earlier this year won distribution through Walgreens and Duane Reade of its arnica gel Arnicare. And Arnicare already is the natural channel’s fastest-growing homeopathic topical pain relief brand, experiencing growth of 67.5% against sales of $5.9 million for the 52 weeks ended April 17, according to Nielsen. 


January 28, 2011

A drug made by Johnson & Johnson may be effective in reducing pain in patients with a complication of diabetes, according to a late-stage clinical study.

RARITAN, N.J. — A drug made by Johnson & Johnson may be effective in reducing pain in patients with a complication of diabetes, according to a late-stage clinical study.

November 4, 2010

The Food and Drug Administration has approved a new usage for a drug used to...

INDIANAPOLIS The Food and Drug Administration has approved a new usage for a drug used to treat depression and pain.

Eli Lilly said Thursday that the FDA had approved Cymbalta (duloxetine hydrochloride) for treating chronic musculoskeletal pain. This is the fifth indication for which the agency has approved Cymbalta, after major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain and fibromyalgia, Lilly said.

October 24, 2010

There is a pair of significant reasons sales of external analgesics, including heat and ice...

October 10, 2010

Thermionics’ ThermiPaq products, which now sport an eye-catching yellow “Control Your Pain!” panel as part...

SPRINGFIELD, Ill. —Thermionics’ ThermiPaq products, which now sport an eye-catching yellow “Control Your Pain!” panel as part of a new graphics package, has been a significant driver of growth within the heat/ice packs segment of late.

For the 52 weeks ended Aug. 8, Thermipaq sales were up 27.2%, reaching $6.1 million across food, drug and mass (minus Walmart) outlets, according to SymphonyIRI Group data. That growth is outpacing the category as a whole, which currently is trending up 6.1%.

September 26, 2010

An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in...

RARITAN, N.J. An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in pain intensity compared with placebo in patients with moderate to severe lower back pain, according to results of a late-stage clinical trial announced Monday.

June 6, 2010

As more baby boomers approach their senior years—the oldest of the baby boomers turn 64...

March 14, 2010

It isn’t just the weekend-warriors with aches and pains from the company’s softball game that...